Companies in the life sciences realm are frequently confronted with challenging economic and financial issues. Quant Economics provides strategic advisory services to assist our clients with the following:
Licensing programs
Litigation
Marketing optimization
Risk management
Valuation
Venture capital
Quant Economics bridges the gap between scientific understanding and economic impact. We have generated effective analytics in a range of life science areas including biotechnology, medical devices, and pharmaceuticals.
Project Profiles
Marketing Optimization.
Pharmaceutical companies often invest a tremendous amount of resources in the marketing of prescription drugs. To increase the value of marketing investments, our experts have developed and applied statistical models of physician behavior to optimize sampling and detailing for prescription drugs. Our analytical implementation increased the returns on marketing investments.
Medical Device Competition.
A medical device manufacturer filed claims of unfair competition and false advertising against a competing, incumbent supplier. The alleged false advertising—in the form of marketing brochures and sales tactics—claimed a greater safety risk from use of the entrant’s medical device. Quant Economics conducted economic analysis that isolated the effect of the false advertising on sales and profits of both medical device manufacturers.
Pharmaceutical Patent Infringement.
In complex litigation involving multiple parties, experts at Quant Economics estimated damages due to alleged patent infringement by a large pharmaceutical company. The asserted patent, which was jointly developed by academic institutions and a biotechnology company, related to inflammatory processes. Our team evaluated the economic contribution of the patented technology and determined a reasonable royalty.
|
